CS logo
small CS logo
Centre d'Oncologie et de Radiothérapie 37

Chambray Les Tours, France
Médecin à Chambray-lès-Tours

About Centre d'Oncologie et de Radiothérapie 37


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centre d'Oncologie et de Radiothérapie 37


During the past decade, Centre d'Oncologie et de Radiothérapie 37 conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Centre d'Oncologie et de Radiothérapie 37" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "OSE Immunotherapeutics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Centre d'Oncologie et de Radiothérapie 37


According to Clinical.Site data, the most researched conditions in "Centre d'Oncologie et de Radiothérapie 37" are "Advanced Cancer" (1 trials), "Advanced Non-small Cell Lung Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Endometrial Cancer" (1 trials) and "Epithelial Ovarian Cancer" (1 trials). Many other conditions were trialed in "Centre d'Oncologie et de Radiothérapie 37" in a lesser frequency.

Clinical Trials Intervention Types at Centre d'Oncologie et de Radiothérapie 37


Most popular intervention types in "Centre d'Oncologie et de Radiothérapie 37" are "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Chemotherapy" (1 trials), "OSE2101" (1 trials), "Pembrolizumab 25 MG/ML [Keytruda]" (1 trials) and "Therapeutic education program" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centre d'Oncologie et de Radiothérapie 37


The vast majority of trials in "Centre d'Oncologie et de Radiothérapie 37" are 3 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Centre d'Oncologie et de Radiothérapie 37


Currently, there are NaN active trials in "Centre d'Oncologie et de Radiothérapie 37". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centre d'Oncologie et de Radiothérapie 37, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre d'Oncologie et de Radiothérapie 37, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".